Study Design
Subject Type
Human
Trial Design
Open-Label
Trial Duration
30 days
Participants
30 (30 completed)
Age Range
29-59 years
Efficacy
Intervention(s) Outcome
Melasma
Sign in to read for free
Study Summary
Sign in to read for free